Pipeline

Research Pre-clinical development Phase I Phase II
ADC-1013* (CD40)
ATOR-1015 (OX40/CTLA-4)
ATOR-1016 (TNFR-SF/TAA)
(TNFR-SF)
(TNFR-SF/ND)

TNFR-SF: Tumor Necrosis Factor Receptor-Superfamily
TAA: Tumor-Associated Antigen
ND: Not Disclosed

*Partnered with Janssen Biotech Inc., developed as JNJ-64457107